Site Search
Professionals 212 results
Capabilities 53 results
Industry
Winston has been a major player in the life sciences industry for decades. We represent market-leading clients across this broad sector, including companies involved in pharmaceuticals, biologics, biosimilars, biotechnology, and medical devices. Our attorneys are seasoned practitioners—many of whom have technical degrees in areas key to the life sciences sector, including biology, chemistry, pharmacy, and biomedical engineering—and bring a unique understanding of the industry and perspective to our representations.
Industry
The medical device industry is currently undergoing monumental change—from supply chain challenges to disruptive technologies and economic fluctuations. To pave the way for a more accessible and innovative healthcare landscape—including advances in wearables, implants, diagnostics, mobility, drug delivery—the evolving and expansive medical device industry faces wide-ranging legal needs. Clients in this sector can tap the remarkable depth and breadth of our sector-focused and skilled attorneys in the U.S. and abroad. Our Healthcare & Life Sciences Industry Group engages clients at all points in the product development life cycle to provide sound advice and practical solutions regardless of the client’s size or the complexity of their need. We help clients navigate today’s complex regulatory landscape, defend products and reputations in the face of high-profile product liability and mass tort claims, protect innovative intellectual property (IP), and leverage cross-border experience to advise on commercial transactions.
Experience 26 results
Experience
|April 23, 2025
Voyager Acquisition Corp. and VERAXA Biotech Announce Business Combination
Winston & Strawn represented Voyager Acquisition Corp. in its announced business combination agreement with VERAXA Biotech AG, a biopharmaceutical company developing next-generation antibody-based cancer therapies. The combination will result in VERAXA becoming a publicly traded company on Nasdaq under the ticker symbol “VERX”, with a pre-money equity valuation of $1.3 billion and up to $253 million in cash held in trust by Voyager. The transaction is expected to close in the fourth quarter of 2025, subject to regulatory and shareholder approvals.
Experience
|October 3, 2024
Drilling Tools International Corp. in its Acquisition of European Drilling Projects
Winston & Strawn represented Houston-based Drilling Tools International Corp. (NASDAQ: DTI) (DTI), a global oilfield services company that designs, engineers, manufactures, and provides a differentiated, rental-focused offering of tools for use in onshore and offshore drilling operations, as well as other cutting-edge solutions across the well life cycle, in its acquisition of Amsterdam-based European Drilling Projects (EDP), a global provider of next-generation stabilizers, specialty reamers, and wellbore optimization technology for the drilling industry. The integration of EDP's expertise aligns seamlessly with DTI's international growth strategy and commitment to technological differentiation. The acquisition of EDP not only enhances DTI's competitive edge but also reinforces its position as a leader in providing innovative drilling solutions to the global oil and gas industry.
Experience
|April 29, 2024
Winston advised the partners of BCF Life Sciences Group in its sale to Sparkfood
A Winston Paris team advised the partners of Diorren SAS, the holding company of BCF Life Sciences ("BCF"), in the sale of BCF Life Sciences Group to Sparkfood, SA, a subsidiary of the listed Sonae group.
Insights & News 1,160 results
Product Liability & Mass Torts Digest
|April 3, 2026
|8 Min Read
A Recipe for Exclusion: Why the Baby Food MDL Experts Failed Under Daubert
In a high-stakes decision on expert exclusion authored late last month, the District Court for the Northern District of California granted defendants’ motion to exclude plaintiffs’ general causation expert witnesses in In re Baby Food Products Liability Litigation—a consolidated mass tort of over 100 pending cases regarding the alleged presence of toxic heavy metals in baby food.
Recognitions
|March 27, 2026
|Less Than 1 Min Read
Winston Paris Recognized in The Legal 500 EMEA 2026
Winston & Strawn’s Paris office has been ranked in the 2026 edition of The Legal 500 EMEA across nine practice areas:
Sponsorship
|March 23, 2026
Winston & Strawn Sponsors Healthcare Business International (HBI) 2026
We are proud to be an Elite Sponsor of the 2026 Healthcare Business International Conference in Paris. This must-attend event brings together leading decision-makers from the global for-profit healthcare sector to explore new business opportunities, drive growth, and shape the future of healthcare.
Other Results 46 results
Site Content
Site Content
Emerging technology is a term generally used to describe a new technology, but it may also refer to the continuing development of an existing technology; it can have slightly different meaning when used in different areas, such as media, business, science, or education. The term commonly refers to technologies that are currently developing, or that are expected to be available within the next five to ten years, and is usually reserved for technologies that are creating, or are expected to create, significant social or economic effects.
Law Glossary
Consumer privacy law is the legal area covering violations of personal information and the right to privacy in everyday life, including violations relating to technology use and finances. Consumer privacy laws and regulations protect individuals from privacy loss due to the failures and limitations of corporate customer privacy measures. The Federal Trade Commission (FTC) is the primary agency directing federal privacy policies and enforcing associated regulations. The FTC utilizes law enforcement, creates policy, and educates consumers as it acts to protect privacy. Legal action can be taken against organizations that violate consumer privacy rights, especially regarding sensitive information.